Many antipsychotic drugs accordingly target the dopamine system; meta-analyses of placebo-controlled trials of these drugs, however, show either no significant difference between drug and placebo, or a very small effect size , suggesting that the pathophysiology of psychosis is much more complex than an overactive dopamine system.